Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret Stock
Equities
ANGEN
TREANGN00028
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.19 TRY | -1.73% | +6.85% | +13.98% |
Sales 2021 | 410M 12.71M | Sales 2022 | 269M 8.33M | Capitalization | 4.74B 147M |
---|---|---|---|---|---|
Net income 2021 | 433M 13.42M | Net income 2022 | 330M 10.23M | EV / Sales 2021 | 6.59 x |
Net cash position 2021 | 511M 15.82M | Net cash position 2022 | 411M 12.75M | EV / Sales 2022 | 16.1 x |
P/E ratio 2021 |
5.1
x | P/E ratio 2022 |
14.3
x | Employees | 171 |
Yield 2021 * |
-
| Yield 2022 |
2.76% | Free-Float | 25.33% |
1 day | -2.63% | ||
1 week | +5.87% | ||
Current month | +5.87% | ||
1 month | +1.66% | ||
3 months | -0.28% | ||
6 months | +2.03% | ||
Current year | +12.93% |
Managers | Title | Age | Since |
---|---|---|---|
Elif Akyuz
FOU | Founder | 49 | 10-06-10 |
Alper Akyuz
CEO | Chief Executive Officer | 54 | 10-06-10 |
Director of Finance/CFO | 37 | 20-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alper Akyuz
CEO | Chief Executive Officer | 54 | 10-06-10 |
Elif Akyuz
FOU | Founder | 49 | 10-06-10 |
Director of Finance/CFO | 37 | 20-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 14.19 | -1.73% | 2 226 619 |
24-05-06 | 14.44 | +1.62% | 4,613,555 |
24-05-03 | 14.21 | +5.34% | 3,979,611 |
24-05-02 | 13.49 | +1.58% | 2,279,924 |
24-04-30 | 13.28 | -1.12% | 1,732,555 |
Delayed Quote Borsa Istanbul, May 07, 2024 at 06:49 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+12.93% | 98.32M | |
+22.81% | 46.81B | |
+46.68% | 41.29B | |
-1.88% | 41.37B | |
-6.20% | 28.87B | |
+11.33% | 26.06B | |
-21.00% | 19.13B | |
-1.43% | 11.96B | |
+30.73% | 12.39B | |
-0.48% | 12.08B |
- Stock Market
- Equities
- ANGEN Stock